Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
1.990
-0.010 (-0.50%)
At close: Oct 24, 2025, 4:00 PM EDT
1.980
-0.010 (-0.50%)
After-hours: Oct 24, 2025, 5:54 PM EDT
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $125.46 million as of October 24, 2025. Its market cap has increased by 276.76% in one year.
Market Cap
125.46M
Enterprise Value
94.03M
1-Year Change
276.76%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since November 10, 2005, Opus Genetics's market cap has increased from $102.90M to $125.46M, an increase of 21.93%. That is a compound annual growth rate of 1.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 119.20M | 217.02% |
| Dec 31, 2024 | 37.60M | -44.79% |
| Dec 29, 2023 | 68.10M | -7.22% |
| Dec 30, 2022 | 73.40M | 13.80% |
| Dec 31, 2021 | 64.50M | 783.56% |
| Dec 31, 2020 | 7.30M | -5.19% |
| Dec 31, 2019 | 7.70M | -77.94% |
| Dec 31, 2018 | 34.90M | -45.55% |
| Dec 29, 2017 | 64.10M | 90.21% |
| Dec 30, 2016 | 33.70M | -48.63% |
| Dec 31, 2015 | 65.60M | -47.44% |
| Dec 31, 2014 | 124.80M | 66.84% |
| Dec 31, 2013 | 74.80M | 152.70% |
| Dec 31, 2012 | 29.60M | -17.55% |
| Dec 30, 2011 | 35.90M | -61.73% |
| Dec 31, 2010 | 93.80M | 91.82% |
| Dec 31, 2009 | 48.90M | -2.00% |
| Dec 31, 2008 | 49.90M | -55.96% |
| Dec 31, 2007 | 113.30M | 66.86% |
| Dec 29, 2006 | 67.90M | -25.71% |
| Dec 30, 2005 | 91.40M | -11.18% |
| Nov 10, 2005 | 102.90M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.08B |
| Johnson & Johnson | 462.74B |
| AbbVie | 403.22B |
| UnitedHealth Group | 326.45B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.86B |
| Abbott Laboratories | 219.89B |